Nastech to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008

  
    
  
  
    
      Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that 
      its first quarter financial results will be released on Thursday, May 8, 
      2008, at 4:00 p.m. Eastern Time (1:00 p.m. Pacific Time). Management 
      will then host a conference call beginning at 4:30 p.m. Eastern Time 
      (1:30 p.m. Pacific Time) to discuss first quarter financial results and 
      provide a corporate update.
    
    
      To participate in the live conference call, U.S. residents should dial 
      800-638-5439 and international callers should dial 617-614-3945. The 
      passcode for the live conference call is 67443467. To access the 24-hour 
      telephone replay, U.S. residents should dial 888-286-8010 and 
      international callers should dial 617-801-6888. The passcode for the 
      replay is 97916996.
    
    
      Alternatively, to access the live audio webcast for this conference call 
      or the subsequent 30-day archive, please log on to Nastech’s 
      Web site at http://www.nastech.com 
      approximately 15 minutes prior to the conference call in order to 
      register and download any necessary software.
    
    
      About Nastech
    
    
      Nastech is a clinical stage biopharmaceutical company focusing on the 
      development and commercialization of innovative therapeutic products 
      based on its proprietary ribonucleic acid interference technology and 
      proprietary molecular biology-based drug delivery technologies. Nastech 
      and its collaboration partners are developing products for multiple 
      therapeutic areas including diabetes, obesity, osteoporosis, autism, 
      respiratory diseases and inflammatory conditions. Additional information 
      about Nastech is available at http://www.nastech.com.
    
    
      Nastech Forward-Looking Statements
    
    
      Statements made in this news release may be forward-looking statements 
      within the meaning of Federal Securities laws that are subject to 
      certain risks and uncertainties and involve factors that may cause 
      actual results to differ materially from those projected or suggested. 
      Factors that could cause actual results to differ materially from those 
      in forward-looking statements include, but are not limited to: (i) the 
      ability of Nastech or a subsidiary to obtain additional funding; (ii) 
      the ability of Nastech or a subsidiary to attract and/or maintain 
      manufacturing, research, development and commercialization partners; 
      (iii) the ability of Nastech, a subsidiary and/or a partner to 
      successfully complete product research and development, including 
      preclinical and clinical studies and commercialization; (iv) the ability 
      of Nastech, a subsidiary and/or a partner to obtain required 
      governmental approvals; and (v) the ability of Nastech, a subsidiary 
      and/or a partner to develop and commercialize products that can compete 
      favorably with those of competitors. Additional factors that could cause 
      actual results to differ materially from those projected or suggested in 
      any forward-looking statements are contained in Nastech's most recent 
      periodic reports on Form 10-K and Form 10-Q that are filed with the 
      Securities and Exchange Commission. Nastech assumes no obligation to 
      update and supplement forward-looking statements because of subsequent 
      events.